Corpus Intelligence IC Memo — AM 1 MENORAH MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — AM 1 MENORAH MEDICAL CENTER
Investment Committee Memorandum | KS | 137 beds | Grade C | EBITDA uplift $21.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AM 1 MENORAH MEDICAL CENTER

CCN 170182 | JOHNSON, KS | 137 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AM 1 MENORAH MEDICAL CENTER is a 137-bed suburban community hospital in JOHNSON, KS with $289.4M in net patient revenue and a 8.5% operating margin. The hospital serves a payer mix of 37.2% Medicare, 0.1% Medicaid, and 62.7% commercial.

Thesis: Turnaround. Our ML models identify $21.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.5% to 15.8% (+736bps).

Net Revenue HCRIS$289.4M
Current EBITDA COMPUTED$24.5M
Operating Margin COMPUTED8.5%
Occupancy HCRIS73.2%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS17.6%
Distress Probability ML39.7%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
16
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of 8.5% places it above the state median. Among 16 size-comparable peers (68-274 beds), the median margin is -8.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (68-274), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AM 1 MENORAH MEDICAL CENTER (Target)KS137$289.4M8.5%
OVERLAND PARK REGIONAL MED CTRKS271$452.2M35.9%
LAWRENCE MEMORIAL HOSPITALKS110$346.7M-4.0%
ST.FRANCIS HEALTH CENTERKS228$276.6M-13.7%
OLATHE MEDICAL CENTERKS237$272.8M-6.5%
SALINA REGIONAL HEALTH CENTERKS177$226.7M-39.5%
ST. LUKES SOUTHKS91$218.2M-13.1%
HAYS MEDICAL CENTER INC.KS136$215.1M-12.3%
HUTCHINSON REGIONAL MEDICAL CEKS147$132.3M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.1M+210bp18mo
Cost to Collect4.5%2.5%$5.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.5M+122bp9mo
Clean Claim Rate88.0%96.0%$185K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.1M
Cost to Collect
$5.8M
Denial Rate Reduction
$5.7M
A/R Days Reduction
$3.5M
Clean Claim Rate
$185K
Total EBITDA Uplift$21.3M
Current EBITDA$24.5M
+ RCM Uplift+$21.3M
Pro Forma EBITDA$45.8M
Current Margin8.5%
Pro Forma Margin15.8%
WC Released (1x)$11.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$37.7M$374.7M9.94x58.3%
Base (11x exit)10.0x11.0x$37.7M$424.4M11.25x62.3%
Bull Case9.0x11.0x$33.9M$507.0M14.94x71.7%
Bull (12x exit)9.0x12.0x$33.9M$563.1M16.59x75.4%
Bear Case11.0x10.0x$41.5M$256.0M6.17x43.9%
Bear (11x exit)11.0x11.0x$41.5M$295.0M7.11x48.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 68-274 beds
  • Same-state prioritization (n=17)
  • Comp margins: P25=-14.1% / P50=-8.0% / P75=0.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.